Personal Narrative in Changing Drug Policy | Michael Botticelli

This presentation is part of the Addiction Medicine Review Course 2017, an overview of the core elements of addiction medicine, presented by top experts in the field. Together with the other presentation it can serve as a broad review for clinicians, a review of the basics for newcomers, or a starting point for those preparing to sit for the Board of Addiction Exam.

Target Audience

  • Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
  • Primary care clinicians who want to get a better understanding of addiction and manage patients with addictions in their practice
  • Public health officials who want an understanding of the current state of addiction treatment
  • Non-physicians who are involved in the treatment of addiction

Learning Objectives

After viewing this lecture participants should be able to

  1. Use drug policy as a case example of why science and data are insufficient to change public policy (think climate change, immunizations). 
  2. Examine strategies and circumstances that changed our understanding and approach
  3. Discuss how we might use these as a way to move public health policy in an age of diminished scientific influence and extreme confirmation bias
 
Course summary
Available credit: 
  • 0.75 AMA Category 1
  • 0.75 Attendance
Course opens: 
09/01/2017
Course expires: 
09/01/2020
Cost:
$50.00
Rating: 
0

Michael Botticelli is the Executive Director of the Grayken Center for Addiction Medicine at 
Boston Medical Center and a Distinguished Policy Scholar at the Johns Hopkins Bloomberg School of Public Health. 
Prior to this, Michael was the Director of National Drug Control Policy for the Obama Administration. He joined the White House Office of National Drug Control Policy (ONDCP) as Deputy Director in November 2012 and later served as Acting Director.  
     
Mr. Botticelli has more than two decades of experience supporting Americans affected by substance use disorders. Prior to joining ONDCP, he served as Director of the Bureau of Substance Abuse Services at the Massachusetts Department of Public Health, where he successfully expanded innovative and nationally recognized prevention, intervention, treatment, and recovery services for the Commonwealth of Massachusetts. He also forged strong partnerships with local, state, and Federal law enforcement agencies; state and local health and human service agencies; and stakeholder groups to guide and implement evidence-based programs.  
  
Mr. Botticelli holds a Bachelor of Arts degree from Siena College and a Master of Education degree from St. Lawrence University. He is also in long-term recovery from a substance use disorder, celebrating more than 28 years of recovery. 

DISCLOSURE

No relevant financial relationships to disclose

The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.

CSAM designates this edduring internet-based educational activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This credit may also be applied to the CMA Certification in Continuing Medical Education.

Available Credit

  • 0.75 AMA Category 1
  • 0.75 Attendance

Accreditation Period

Course opens: 
09/01/2017
Course expires: 
09/01/2020

Price

Cost:
$50.00
Please login or register to take this course.